Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Nearly a third of families with children receiving chemotherapy for acute lymphoblastic leukemia (ALL)—the most common ...

IV iron improves survival, increases hemoglobin in patients with iron-deficiency anemia and acute infection

Treatment with intravenous (IV) iron significantly improved survival and increased hemoglobin levels in patients with ...

Aza–ven combination outperforms standard care in AML patients eligible for intensive chemotherapy

In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen ...

Trial shows chemotherapy and radiation are comparable as pre-transplant conditioning for patients with B-ALL

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction ...

Microbial molecule that disarms inflammation discovered, offering new diabetes treatment strategy

An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a ...

Most people struggle to meet recommended sleep and physical activity targets: Getting rest is better, says study

Getting enough sleep and staying active are two of the most important things we can do for our health, but new research shows ...

Altering the daily timing of immunotherapy could improve survival in people with cancer

Receiving anticancer immunotherapy earlier in the day may help individuals with cancer live longer. That's according to a ...

Black patients with AML are younger at diagnosis, experience poorer survival outcomes than white patients, data show

Compared with white patients, Black patients with acute myeloid leukemia (AML) were on average more than five years younger at diagnosis, more than 30% more likely to die of their disease, and more ...

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

A new study shows that giving the chemotherapy drug cyclophosphamide after allogeneic hematopoietic cell transplantation, a curative treatment for common types of blood cancer, can make the procedure ...

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

Pirtobrutinib, a non-covalent Bruton tyrosine kinase (BTK) inhibitor, met the primary endpoint for non-inferiority in terms of overall response rate in the first head-to-head comparison with ibrutinib ...